Partnership Opportunities

Ophthalmic focused biotechnology and pharma firms are pushing full speed ahead to make innovative and patient friendly therapies a reality for wet AMD & DME suffering patients. To support the prevention of blindness for potentially millions, the Wet AMD & DME Drug Development Summit brings together pioneering organizations and academics to make the longer duration, non-invasive therapeutics with lower non-responsiveness rates that patients need.

From conducting 1-to-1 research with senior leaders from across industry and academia in this space, we know there is a specific interest in connecting with:

Clinical CROs - Medical Devices - Equipment - Preclinical Research - Ophthalmic Imaging - Ophthalmic Devices - Retinal Organoids - Diagnostic Tools - Drug Delivery Technologies

Why partner with us:

Icon 1
Icon 2
Icon 3
Icon 4

Secure an exhibition booth to showcase your expertise and educate the industry on how you can support and streamline their efforts

Meet with the community face to face for the first time in over a year. This is your opportunity to facilitate lead generation and build new relationships in person, with senior level decision makers from leading pharma and biotech companies

Secure a branding or speaking opportunity to demonstrate your thought leadership, drive your brand exposure and differentiate yourself from competitors

Meet your 2022 business objectives by educating key decision makers on how your expertise can help ensure wet AMD & DME therapies reach full potential and reach patients in need

Attendance by Company Type

seniority

Attendance by Geo

geo (002)

*Audience breakdown based on Dry AMD Therapeutic Development Summit attendee list